 WAYNE, Pa., Aug. 30, 2021 GLOBE NEWSWIRE -- Teleflex Incorporated NYSE: TFX today announced the publication of clinical data for the UroLift System in the peer-reviewed journal Prostate Cancer and Prostatic Disease . This study explains the mechanism of action through which the UroLift System provides long-term durability and sustained results for patients with benign prostatic hyperplasia BPH, also referred to as enlarged prostate. 